Recent Posts
- Voyager Therapeutics Advances Gene Therapy Candidate in Partnership with Neurocrine Biosciences
- Webinar: Treating Autosomal Recessive Deafness 9 with AAV1-hOTOF Gene Therapy (4/24/2024 10:00am EST/ 7:00am PST)
- Biotech Innovators Nvelop Therapeutics and Seaport Therapeutics Launch with $100 Million to Revolutionize Genetic and Neuropsychiatric Treatments
- Exploring the role of RNA modification in normal hematopoiesis and acute myeloid leukemia pathogenesis
- Batavia, Chromatan Receive NIIMBL Grant to Improve AAV Manufacturing
AAV One-stop Solution
Tags
AAV2
AAV5
AAV based gene therapy
AAV Capsid
ALS
Alzheimer’s Disease
brain vasculature
cancer
CAR-T
Cell Therapy
chylomicronemia syndrome
COVID-19
COVID vaccine
CRISPR
CRISPR/Cas
dystrophin
eye disease
FDA
gene editing
gene therapy
genetic engineering
genome editing
GMP plasmid
hearing
heart disease
hemophilia
hepatitis research
HIV
immunotherapy
liver cancer
mRAN
mRNA
Neurodegenerative Diseases
Orphan Drug
Parkinson
PD-1
rare disease
Retinoschisis
RNA
RNAi therapeutics
RNA vaccines
SARS-CoV-2
SMA Treatment
thyroid
zolgensma